UNSPSC 51433917: Isradipine

This classification denotes a calcium channel blocker with the molecular formula C19H21N3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YO1UK1S598, chemically known as 2,1,3-benzoxadiazole, 3,5-pyridinedicarboxylic acid deriv. but generally known as isradipine, which bears US NIH Compound Identifier 3784. European Medicines Agency schedules Isradipine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08346MIG.

UNSPSC 51433917 Isradipine, a Commodity code, covers individual pharmaceutical products used by state and local health agencies, emergency medical services, and public health programs. Recent state and local opportunities solicited under this code show state and local governments purchasing emergency medications, generic pharmaceuticals, and over-the-counter products through both direct procurement and cooperative purchasing arrangements. The scope spans emergency life-support medications supplied to fire rescue operations, generic multi-source pharmaceutical products distributed through authorized wholesalers to state and local facilities, and exploratory procurement for direct-to-manufacturer pharmacy initiatives. Issuing bodies include municipal purchasing departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), with a mix of one-time emergency medication buys and multi-year framework agreements serving multiple participating jurisdictions.

Geographic activity centers on Florida, Texas, Minnesota, and Oregon, with the most recent solicitations occurring in the first four months of 2026. Representative recent opportunities include the City of Tampa's Bid No. 26-P-00188 for Advanced Life Support Medications (posted April 24, 2026; due April 8, 2026), an IFB for 370 units of Labetalol HCI, 1,810 units of Epinephrine, 330 units of Adenosine, and 1,020 units of Diltiazem for Tampa Fire Rescue with an estimated value of $40,000 and a Small Local Business Enterprise sheltered market designation; the Minnesota Multistate Cooperative Purchasing Alliance's RFP (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson to state and local facilities across Minnesota and Oregon; and the Texas HHS Commission's RFI No. HHS0017013 (due April 3, 2026) exploring vendor capabilities for a direct-to-manufacturer prescription program. Opportunities show a mix of short-cycle emergency medication buys, multi-year cooperative pricing frameworks, and exploratory state-level initiatives to restructure pharmaceutical supply arrangements outside traditional pharmacy benefit manager channels.